Cargando…
Efficacy and tolerability of a β-1 selective β blocker, bisoprolol, as a first-line antihypertensive in Indian patients diagnosed with essential hypertension (BRIGHT): an open-label, multicentric observational study
OBJECTIVES: This study was aimed to evaluate the efficacy and tolerability of bisoprolol, in Indian patients diagnosed with stage I essential hypertension as first-line drug. DESIGN: This was an open-label, phase IV, multicentric prospective study. SETTINGS: 239 outpatient centres across India. PART...
Autores principales: | Channaraya, V, Marya, R K, Somasundaram, M, Mitra, Debashish, Tibrewala, K D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358619/ https://www.ncbi.nlm.nih.gov/pubmed/22586283 http://dx.doi.org/10.1136/bmjopen-2011-000683 |
Ejemplares similares
-
Comparison of ivabradine plus β-blockers versus β-blocker therapy only
por: Aalbers, J
Publicado: (2010) -
Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease
por: AlHabeeb, Waleed, et al.
Publicado: (2021) -
Prognostic Value for Incidental Antihypertensive Therapy With β-Blockers in Metastatic Colorectal Cancer
por: Giampieri, Riccardo, et al.
Publicado: (2015) -
β(1)-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart Failure
por: Feuerstein, Thomas J., et al.
Publicado: (2021) -
Effectiveness of β-blockers in physically active patients with hypertension: protocol of a systematic review
por: Tučková, Dagmar, et al.
Publicado: (2016)